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Edited by Julian SchroederAbstract In Xanthomonas campestris, the causative agent of
black rot in crucifers, the endoglucanase level is greatly de-
creased in the mutant deﬁcient in Clp, a homologue of cyclic
AMP receptor protein (CRP). It is established that Clp has
the same DNA binding speciﬁcity as CRP at positions 5, 6,
and 7 (GTG motif) of the DNA half site. In this study, the engA
transcription initiation site was determined by the 5 0 RACE
method, and two consensus Clp-binding sites, site I and site II
centered at 69.5 and 42.5, respectively, were located. Tran-
scriptional fusion assays indicated that Clp greatly activates
engA transcription. Site-directed mutagenesis indicated that po-
sition 5 of GTG motif in site II is essential for both DNA-protein
complex formation in electrophoretic mobility shift assays and
engA transcription in vivo. In addition, mutation at position 5
of site I drastically reduces the promoter activity, indicating that
binding of Clp to site I exerts a synergistic eﬀect on the tran-
scription activation by site II. engA appears to be the ﬁrst X.
campestris gene known to be activated by Clp via a direct bind-
ing to the promoter.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Xanthomonas campestris is the gram-negative bacterium
causing black rot in crucifers [1]. It is capable of producing
great amounts of an exopolysaccharide, xanthan gum, and
secreting several extracellular enzymes including proteases,
pectinases, and endoglucanases. These extracellular products
have long been considered important virulence factors of
X. campestris [2–5].
Two major endoglucanase activities of X. campestris have
been reported, and only the endoglucanase encoded by engA
has been sequenced [6,7]. EngA, a 53-kDa extracellular protein
possessing a domain conserved in members of cellulase family
A, shares strong sequence homology with an endoglucanse
from Cellulomonas ﬁmi [7].*Corresponding author. Fax: +886 4 2239 5474.
E-mail address: yhtseng@chtai.ctc.edu.tw (Y.-H. Tseng).
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doi:10.1016/j.febslet.2005.05.023Regulation of the X. campestris engA is still unclear. It is
only known that the endoglucanase level is decreased by 85%
after mutation of clp gene, coding for the global transcription
factor Clp (cyclic AMP receptor protein-like protein), which
also regulates the secretion of several other extracellular en-
zymes, pigmentation, the production of xanthan polysaccha-
ride, pathogenicity, and the synthesis of cell surface structure
required for the infection of ﬁlamentous phage /Lf [8–10].
In addition to Clp, synthesis of these extracellular enzymes
and xanthan polysaccharide is subject to co-ordinate regula-
tion by rpf (regulation of pathogenicity factors) gene cluster
[11–14].
Because of the importance of the extracellular enzymes of
X. campestris, it was interesting to know how their syntheses
are regulated. We have previously shown that expression of
the major protease gene prt1 is upregulated by Clp in an indi-
rect manner, in which activation does not involve a direct
binding of Clp to the promoter [15,16]. This study describes
transcriptional regulation of engA, whose promoter has tan-
dem Clp-binding sites. Our results of transcriptional fusion as-
says and electrophoretic mobility shift analyses, using the wild
type and the mutated promoter regions, indicate that Clp
activates the transcription of engA by a direct binding to the
promoter region.2. Materials and methods
2.1. Bacterial strains, plasmids, and growth conditions
The bacterial strains and plasmids used in this study are listed in Ta-
ble 1. Luria-Bertani (LB) broth and L agar were the general-purpose
media for bacterial cultivations [17]. Escherichia coli and X. campestris
strains were grown at 37 C and 28 C, respectively, with vigorous
shaking. Antibiotics were added when necessary: ampicillin (50 lg/
ml), kanamycin (50 lg/ml), and tetracycline (15 lg/ml).
2.2. DNA techniques
Restriction enzymes, T4 DNA ligase, and Taq polymerase were pur-
chased from Promega. Protocols for DNA manipulations, including
plasmid DNA preparation, restriction endonuclease digestion, agarose
gel electrophoresis, and isolation and ligation of DNA fragments have
been described elsewhere [18]. E. coli DH5a was transformed by the
standard method [18] and X. campestris strains by electroporation
[19]. The DNA sequences on both DNA strands were determined by
the dideoxy chain termination method [20]. PCR was carried out as
previously described [15]. The reactions were initiated with a hot startblished by Elsevier B.V. All rights reserved.
Table 1
Bacterial strains and plasmids used in this study
Strain or plasmid Descriptions Reference or source
E. coli
DH5a F endA1 hsdR17 ðrK Þ supE44thi-1krecA1deoR gyrA96relA1D(argF-lacZYA) U169/80dlacZDM15 [42]
BL21(DE3) FompT hsdSB ðrB mB Þ gal dcm (DE3) Novagen
X. campestris
Xc17 Virulent wild type strain isolated in Taiwan, Apr [43]
AU56E clp mutant derived from XC17 by Tn5(pfm)CmKm insertion, APr, Cmr, Kmr [10]
Cloning and expression vector
pTAdv PCR cloning vector, Apr, Kmr Clontech
pET30b Expression vector, Kmr Novagen
pMCL5clp pET30b derivative carrying the 0.7-kb NdeI–XhoI fragment of the Xc17 clp gene This study
Transcriptional fusion construct
pFY13-9 Promoter-probing vector derived from pRK415, using lacZ as the reporter, Tcr [9]
pFY524+22 The 546-bp fragment, 524/+22 relative to engA TIS, cloned in PstI/XbaI sites of pFY13-9 This study
pFY330+22 The 352-bp fragment, 330/+22 relative to engA TIS, cloned in PstI/XbaI sites of pFY13-9 This study
pFY239+22 The 261-bp fragment, 239/+22 relative to engA TIS, cloned in PstI/XbaI sites of pFY13-9 This study
pFY137+22 The 159-bp fragment, 137/+22 relative to engA TIS, cloned in PstI/XbaI sites of pFY13-9 This study
pFY81+22 The 103-bp fragment, 81/+22 relative to engA TIS, cloned inPstI/XbaI sites of pFY13-9 This study
pFY81+22(I5C) pFY81+22 derivative carrying a Gﬁ C mutation at position 5 of site I This study
pFY81+22(II5C) pFY81+22 derivative carrying a Gﬁ C mutation at position 5 of site II This study
pFY81+22(I/II5C) pFY81+22 derivative carrying a Gﬁ C mutation at position 5 of both site I and II This study
pFY81+22(I6A) pFY81+22 derivative carrying a Tﬁ A mutation at position 6 of site I This study
pFY81+22(II6A) pFY81+22 derivative carrying a Tﬁ A mutation at position 6 of site II This study
pFY81+22(I/II6A) pFY81+22 derivative carrying a Tﬁ A mutation at position 6 of both site I and II This study
pFY81+22(I7C) pFY81+22 derivative carrying a Gﬁ C mutation at position 7 of site I This study
pFY81+22(I7C) pFY81+22 derivative carrying a Gﬁ C mutation at position 7 of site II This study
pFY81+22(I/II7C) pFY81+22 derivative carrying a Gﬁ C mutation at position 7 of both site I and II This study
pFY23940 The 200-bp fragment, 239/40 relative to engA TIS, cloned in PstI/XbaI sites of pFY13-9 This study
pFY13740 The 98-bp fragment, 137/40 relative toengA TIS, cloned in PstI/XbaI sites of pFY13-9 This study
pFY13731 The 107-bp fragment, 137/31 relative toengA TIS, cloned in PstI/XbaI sites of pFY13-9 This study
pFY1376 The 132-bp fragment, 137/6 relative to engA TIS, cloned in PstI/XbaI sites of pFY13-9 This study
Apr, ampicillin-resistant; Cmr, chloramphenicol-resistant; Kmr, kanamycin-resistant; Tcr, tetracycline-resistant.
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denaturation at 94 C for 1 min, annealing at 55 C for 1 min, and
elongation at 72 C for 1 min, which were then followed by a ﬁnal
extension time of 7 min.
2.3. Mapping the 5 0 end of the engA mRNA
The 5 0 RACE (rapid ampliﬁcation of cDNA ends) system [21] was
used to determine the transcription initiation site with the kit (Version
2.0) purchased from Invitrogen Corporation (Carlsbad, California).
Total RNA was isolated from Xc17 (mid-exponential phase) by the
Qiagen RNA extraction system (Qiagen Inc., Valencia, CA) according
to the instructions provided by the supplier. The Abridged Anchor Pri-
mer and Abridged Universal Ampliﬁcation Primers were used in com-
bination with the gene speciﬁc primers. The gene-speciﬁc primers for
RT-PCR, nested PCR1, and nested PCR2 were 1459R (complemen-
tary to engA nt 416–435, 5 0-CTCGGAAATGCCGGCGCAAT-3 0),
1347R (complementary to engA nt 304–323, 5 0-AGGTCGGC-
GTTGCGGCTGTA-3 0), and 1141R (complementary to engA nt
98–117, 5 0-GCCGCTGTCGTCGACGATCT-3 0), respectively. The
PCR products were directly ligated into pTAdv vector (Clontech, Palo
Alto, CA) which had the M13 forward and reverse primers for
sequence veriﬁcation.
2.4. Preparation of PengA-lacZ transcriptional fusion constructs and
measurement of b-galactosidase activity
Nested deletions of the Xc17 engA promoter region were obtained
by PCR ampliﬁcation with chromosomal DNA as the template, using
the primers listed in Table 2. Eighteen PengA-lacZ transcriptional fu-
sion constructs were generated (Table 1) and separately introduced
into X. campestris strains by electroporation. Similar amounts of the
transformant cells were subjected to assays for b-galactosidase levels
expressed by the promoter regions, after growing in the LB medium
for 48 h. The enzyme levels were expressed as Miller units [17].2.5. Overproduction and puriﬁcation of Clp protein
The coding region of Xc17 clp (690 bp) was PCR-ampliﬁed and
cloned into the NdeI–XhoI sites of pET30b (Novagen), generating
pMCL5clp. This construct encoded the complete Clp plus six histidine
residues at the C-terminus. E. coli BL21(DE3)(pMCL5clp) was grown
in the LB medium in presence of IPTG (1.0 mM). Clp was puriﬁed
from the crude extracts prepared from a 100-ml culture using Bug-
Buster protein extraction reagent and the His-Bind aﬃnity column
(Novagen, Madison, WI). Protein purity was checked by SDS–poly-
acrylamide gel electrophoresis (SDS–PAGE) followed by Coomassie
blue staining of the protein bands [22]. The puriﬁed protein was dia-
lyzed against 1 l of phosphate buﬀer (50 mM potassium phosphate,
pH 7.0 containing 0.5 M KCl, 1 mM EDTA, 0.2 mM DTT and 5%
glycerol) at 4 C with three changes of the buﬀer. The protein was then
concentrated with Ultrafree-0.5 centrifugal ﬁlter device (Millipore,
Bedford, MA) and stored in aliquots in 50% (v/v) glycerol at 20 C
until used.2.6. Electrophoretic mobility shift assay
The DNA probes used for electrophoretic mobility shift assay
(EMSA) analysis were prepared by PCR ampliﬁcation of the desired
regions of the X. campestris engA promoter, using 5 0-end biotin-labeled
synthetic oligonucleotides as the primers (Table 2). The amplicons
were puriﬁed from agarose gels and used for gel-shift experiments.
The EMSA reaction mixture (20 ll) contained ca. 1.0 pmol of biotin-
labeled probe and various amounts of Clp in the binding buﬀer
[10 mM Tris–HCl, pH 7.5 containing 50 mM KCl, 1 mM EDTA,
1 mM dithiothreitol (DTT), and bovine serum albumin (BSA)
(50 lg/ml)] containing 1 lg of nonspeciﬁc competitor DNA poly(dI-
dC) (Amersham Pharmacia Biotech, Piscataway, NJ). Following incu-
bation at room temperature for 30 min, the DNA-protein complexes
were subjected to electrophoresis in a native 4.5% polyacrylamide gel
[acrylamide:bisacrylamide, 30:0.8 (w/w)] in 0.5· TBE buﬀer (45 mM
Table 2
Primers used for PCR ampliﬁcation of the engA promoter regions
Primer Sequencea Siteb Direction and usec
457pstI 5 0-AACTGCAGCTGCTGACAAAGCGCATCAGCA-30 524 Forward, TFC
643pstI 5 0-AACTGCAGGAATTCCCGGGGATCACAAACG-30 330 Forward, TFC
742pstI 5 0-AACTGCAGGCAACGGCGCCAGCCATCAGTT-30 239 Forward, TFC
844pstI 5 0-AACTGCAGCCTGCGGACAGCGCGCAGGGGG-30 137 Forward, TFC
900pstI 5 0-AACTGCAGGCGATGTGATCGGTGCGGCAAT-30 81 Forward, TFC and EMSA
925F 5 0-GTTTTCTGTGGGGACGATCACA-30 56 Forward, EMSA
950F 5 0-CGCGACGCGCGCACAGACCAAG-30 31 Forward, EMSA
900pstI(I5C) 5 0-AACTGCAGGCGATCTGATCGGTGCGGCAAT-30 81 Forward, mutation of site I
900pstI(II5C) 5 0-AACTGCAGGCGATGTGATCGGTGCGGCAATGGT GTTTTCTCTGGG-30 81 Forward, mutation of site II
900pstI(I/II5C) 5 0-AACTGCAGGCGATCTGATCGGTGCGGCAATGGT GTTTTCTCTGGG-30 81 Forward, mutation of site I and site II
900pstI(I6A) 5 0-AACTGCAGGCGATGAGATCGGTGCGGCAAT-30 81 Forward, mutation of site I
900pstI(II6A) 5 0-AACTGCAGGCGATGTGATCGGTGCGGCAATGGT GTTTTCTGAGGG-30 81 Forward, mutation of site II
900pstI(I/II6A) 5 0-AACTGCAGGCGATGAGATCGGTGCGGCAATGGT GTTTTCTGAGGG-30 81 Forward, mutation of site I and site II
900pstI(I7C) 5 0-AACTGCAGGCGATGTCATCGGTGCGGCAAT-30 81 Forward, mutation of site I
900pstI(II7C) 5 0-AACTGCAGGCGATGTGATCGGTGCGGCAATGGT GTTTTCTGTCGG-30 81 Forward, mutation of site II
900pstI(I/II7C) 5 0-AACTGCAGGCGATGTCATCGGTGCGGCAATGGT GTTTTCTGTCGG-30 81 Forward, mutation of site I and site II
940xbaI 5 0-GCTCTAGACGTCCCCACAGAAAACACCATT-30 40 Reverse, TFC
950xbaI 5 0-GCTCTAGAGTGGTGTGATCGTCCCCACAGA-30 31 Reverse, TFC
975xbaI 5 0-GCTCTAGAGCATCTTGGTCTGTGCGCGCGT-30 6 Reverse, TFC
1002xbaI 5 0-GCTCTAGAGCTCGACACCCGAGCGCGGTAA-30 +22 Reverse, TFC
1002R 5 0-GCTCGACACCCGAGCGCGGTAA-30 (50 biotin labeled) +22 Reverse, EMSA
1056R 5 0-GCGAGCGTGCTTGCGGTCCTGA-30 (50 biotin labeled) +76 Reverse, EMSA
aAdded restriction sites are underlined. The mutated bases are in boldface and double underlined.
bPosition of the 50-end of the oligonucleotides relative to TIS of engA gene.
cTFC, transcriptional fusion construct; EMSA, electrophoretic mobility shift assay.
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electrophoresed at 100 V, and the gel was transferred to positively
charged nylon membranes (Roche Diagnostics GmbH, Mannheim,
Germany). After UV cross-linking, the biotinylated probes in mem-
brane were detected using the LightShiftTM Chemiluminescent EMSA
kit (PIERCE). The ratios of bound to unbound probes were calculated
by the intensities of the bands scanned by AlphaImagerTM 1200 gel
documentation system (Clontech).
2.7. Protein determination
Protein contents were determined by the method of Bradford [23]
using protein assay reagent purchased from Bio-Rad Laboratories
(Hercules, CA) with bovine serum albumin (BSA) as the standard.3. Results and discussion
3.1. The engA upstream region possesses two Clp-binding sites
To map the transcription initiation site (TIS) of the
X. campestris engA, the 5 0 RACE method was employed.
Sequencing of the two fragments generated by nested PCR,
197 and 403 bp (Fig. 1A), showed that transcription was initi-
ated at nucleotide T, 44 nt upstream from the translation start
codon (Fig. 1B). A putative ribosome binding site (GGAG)
was present 7 nt upstream of the translation start codon
(Fig. 1B). A possible sigma 70 promoter with a 10 box
(CAAGAT) and a 35 box (ATCACA) located at 8 and
35 (with a spacer of 21 nt) relative to the TIS, respectively.
The E. coli CRP-binding site (5 0-AAATGTGA-TCTAGA-
TCACATTT-3 0) is 22 bp long exhibiting perfect twofold se-
quence symmetry, with the bold-faced bases representing
the left and right arms each for the binding of one subunit
of the active CRP dimer [24,25]. Using mutant sequences of
the E. coli lac promoter as the substrates, the X. campestris
Clp has been shown to have the same DNA binding speci-
ﬁcity as CRP at positions 5, 6, and 7 (GTG motif) of the
DNA half site [26]. Two consensus Clp-binding sites with
a spacer of 27 nt were present at nt 80 to 59 (site I, cen-tered at 69.5) and 53 to 32 (site II, centered at 42.5)
relative to TIS (Fig. 1B). Site I contained a perfect TGTGA
block in the left arm and a 2/5 matched block, CGGCA, in
the right arm. Site II had a 4/5 matched block (TGTGG) in
the left arm and a perfect block (TCACA) in the right arm
(Fig. 1B).
3.2. The engA upstream region 137/+22 relative to TIS is
capable of maximal-level expression
The promoter-probing vector pFY13-9 was constructed in
our laboratory and has been used for promoter assays with
several X. campestris promoters [9,27]. This vector was also
used for promoter assays in this study. To assure that expres-
sion of the reporter b-galactosidase was not aﬀected by the
pleiotropic eﬀects of clp mutation, we had introduced a tran-
scriptional fusion construct containing the promoter of the
Xc17 trehalase gene (treA, a non-clp regulated gene) into
Xc17 and AU56E, then measured the b-galactosidase activities
expressed. The results indicated that, although the enzyme le-
vel changed following cell growth, the treA promoter activities
were the same in both strains at corresponding time points
(data not shown), indicating that expression of the reporter en-
zyme was not aﬀected by clp mutation. To map the upstream
region required for expression of the engA gene, nine of the
PengA-lacZ transcriptional fusion constructs were used to as-
say for promoter activity in the wild-type Xc17 grown in LB
(Table 1, Fig. 2). In preliminary experiments, the b-galactosi-
dase levels were found to increase following cell growth until
about 30–48 h depending on the regions cloned (data not
shown). Therefore, the b-galactosidase levels were measured
at 48 h throughout this study. As shown in Fig. 2, the highest
levels of enzyme, 8071 to 8310 U, were detected in
Xc17(pFY524+22), Xc17(pFY330+22), Xc17(pFY239+
22) and Xc17(pFY137+22). These data suggest that the com-
plete promoter sequences are included in the 137/+22 region.
The levels of b-galactosidase in Xc17(pFY81+22) and
Fig. 1. (A) Mapping of the 5 0 end of X. campestris engA transcript by 5 0 RACE method. Fragments were ampliﬁed by PCR using the Abridged
Universal Ampliﬁcation Primer (Life Technologies, Inc.) in combination with gene speciﬁc primer 1347R (lane 1) or 1141R (lane 2). Lane M, size
markers. (B) Sequence of the engA upstream region. The transcription initiation site (TIS, +1) identiﬁed is indicated by a vertical arrow. The
predicted 10 and 35 sequences are underlined. The putative ribosomal binding site (RBS) and the translation start codon (ATG) are in boldface
and underlined. The putative Clp-binding sites are boxed. Horizontal arrows indicate the positions and directions of the gene speciﬁc primers that
were used for PCR ampliﬁcation of DNA fragments for RACE products shown in (A).
Fig. 2. Deletion mapping of the X. campestris engA promoter region. Horizontal lines indicate the regions cloned to form the PengA-lacZ
transcriptional fusion constructs. Numbers after pFY are nucleotide positions relative to the engA TIS. b-Galactosidase activity (Miller units) was
measured in Xc17 and AU56E cells containing diﬀerent constructs.
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tively) than that expressed by Xc17(pFY137+22), 8149 U
(Fig. 2). The fact that expression from pFY81+22, whose in-
sert contained the complete 10 and 35 regions and regula-
tory elements, gave lower activity (70% of pFY137+22)suggests that region 137/81 can somehow enhance the pro-
moter activity. The remaining clones, Xc17(pFY23940),
Xc17(pFY13740) and Xc17(pFY13731), displayed the
same levels of enzyme as that by Xc17(pFY13-9) without the
engA promoter (43 U) as shown in Fig. 2, indicating that the
Y.-M. Hsiao et al. / FEBS Letters 579 (2005) 3525–3533 3529239/31 region excluding the 10 box is not suﬃcient for
expressing signiﬁcant levels of promoter activity.
3.3. The engA promoter requires Clp for expression
AU56E is a clp mutant isolated by Tn5 insertion, whose
mutation causes pleiotropic eﬀects including drastic reductions
in the synthesis of xanthan polysaccharide and extracellular
enzymes (protease, cellulase and pectinase), loss of virulence,
and resistance to ﬁlamentous phage /Lf [9,10]. These proper-
ties are similar to those reported by de Crecy-Lagard et al. [8],
except that the protease level is on the contrary increased in
their clp mutant. To test for the involvement of Clp in tran-
scription of engA, the transcriptional fusion constructs (Table
1) were introduced into AU56E and the resultant strains were
subjected to b-galactosidase assays. As shown in Fig. 2, the b-
galactosidase levels in these strains ranged from 43 to 84 U,
which were as low as that displayed by AU56E(pFY13-9)
without the engA promoter (31 U), indicating that Clp is in-
deed required for transcription of the engA gene.3.4. EMSA analysis showed that Clp directly binds to the engA
promoter
To test whether transcriptional regulation of engA is
achieved by a direct binding of Clp to the promoter region,
EMSA analyses were performed using the PCR-ampliﬁed
103 bp 81/+22 fragment (probe a, Fig. 4A) and the pET-ex-
pressed Clp protein which had been puriﬁed by passing
through a His-bind aﬃnity column. The puriﬁed Clp formed
one major protein band in SDS–polyacrylamide gel stained
with Coomassie blue (data not shown). As a negative control,
EMSA was performed in parallel using the promoter region
of prt1 gene which is regulated by Clp indirectly, i.e. without
a direct binding of Clp to the promoter [15]. As shown in
Fig. 3A, a stable DNA-protein complex was formed that mi-
grated at a slower rate than the unbound probe. WithFig. 3. EMSA showing dose responses of Clp binding to the promoter regio
campestris prt1 as a control (B). Diﬀerent amounts of puriﬁed Clp protein, i
promoter region (81/+22, probe a) or prt1 promoter region correspondingincreasing amounts of Clp, from 50 to 500 ng per reaction,
the bound probe increased from 54% to 90% (Fig. 3A). In
other words, complex formation with the biotin-labeled frag-
ments was in a Clp concentration-dependent manner. In con-
trast, Clp could not form a DNA-protein complex with the
prt1 promoter (Fig. 3B), indicating that Clp does not bind
to general DNA promoter elements and thus demonstrating
its binding speciﬁcity.
3.5. The engA upstream region, 56/31 relative to TIS, is
suﬃcient for Clp to bind in vitro
To narrow down the engA promoter region required for Clp
to bind, three more probes were prepared by PCR ampliﬁca-
tion using biotin-labeled primers (Table 2). Probes b, c, and
d were fragments corresponding to nucleotide positions
81/+76, 56/+76, and 31/+76 relative to engA TIS, respec-
tively (Fig. 4A). To assure further puriﬁcation, the right ends
of these probes were extended 76 nt into the engA gene to ob-
tain a fragment length of over 100 bp following the suggestion
from the supplier (PROTECH). In EMSA, mobility of probes
b and c, in addition to probe a, were found to be retarded by
Clp, whereas probe d was not retarded (Fig. 4B). These data
indicate that the sequences for Clp to bind do not reside in
31/+76, whereas region 56/31 appears to possess com-
plete sequence for Clp to bind. Since region 56/31 con-
tained only site II, the above data did not clarify whether
site I is involved in Clp binding in vitro. With the region
81/57 containing only site I, no DNA-protein complex
was detected (data not shown) indicating that only site II
was responsible for Clp to bind in our in vitro assay condi-
tions. In these EMSA experiments, probe b was found to bind
less Clp than probe a (Fig. 4B). It is possible that including of
+22/+76 region had caused conformational changes rendering
the sites less accessible to Clp. Whether the upstream coding
region of engA plays a role in regulating its own expression will
be an interesting topic for further study.n of the X. campestris engA (A), using the promoter region of the X.
ndicated above the lanes, were incubated with the biotin-labeled engA
to 392/207 relative to the translation start site [15].
Fig. 4. (A) Positions of the PCR fragments, used as the probes in
EMSA, relative to TIS of the X. campestri engA. Primers used for PCR
ampliﬁcation are listed in Table 2. (B) The fragments were used in
EMSA with (+) or without () Clp protein (0.5 lg).
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binding in vitro, but the change made in site II abolishes the
binding activity
To characterize the sequence involved in the formation of
DNA-Clp complex, EMSA was performed using mutant probe
fragments (nt 81 to +22 relative to TIS) created by changing
G to C, T to A, and G to C at position 5, 6, and 7, respectively,
of the GTG motif in either or both of the sites (Fig. 5A).
Probes a, e, f, g, h, i, j, k, l, and m were prepared by PCR
ampliﬁcation using ten diﬀerent forward primers (900pstI
and the nine primers preﬁxed by 900pstI in Table 2) to sepa-
rately pair with the reverse primer 1002R. The EMSA data,
as shown in Fig. 5B and Table 3, indicated that (i) probes e,
h, and k with a mutation at position 5, 6, and 7 of site I, respec-
tively, retained 72% to 81% of the Clp-binding activity, (ii)
probes i and j with a mutation at position 6 of site II and both
sites retained 80% and 58% binding activity, respectively, (iii)
probes l and m with a mutation at position 7 of site II and both
sites retained 46% and 45% binding activity, respectively, and
(iv) a mutation at position 5 of either site II (probe f) or both
sites (probe g) almost abolished the binding activity (9% and
8% remained, respectively). These results suggest that muta-
tion in site I has minor eﬀect on the formation of stable Clp-
engA promoter complex by site II. In addition, a mutation in
site II at GTG motif had diﬀerent degrees of eﬀect on the
Clp-engA promoter complex formation, with the greatest
eﬀects being at position 5 followed by position 7 and then
position 6.
3.7. A change of G to C at position 5 of site I reduces the engA
promoter activity
To test for the eﬀects of mutation in the GTG motif of the
Clp-binding sites on promoter activity, fragments of 81/+22
carrying mutated Clp-binding site(s) were cloned into
pFY13-9 forming transcriptional fusion constructs, which
were introduced into Xc17 followed by assaying the
reporter enzyme levels. The nine constructs thus obtained werecorresponding to probes e, f, g, h, i, j, k, l, and m (Table 3).
Reporter assays showed that pFY81+22(II5C) and
pFY81+22(I/II5C) displayed 137 and 146 U of b-galactosi-
dase, respectively (Table 3), which were only 2.6% and 2.7%
of that in the wild-type pFY81/+22 (5367 U). The promoter
activities of pFY81+22(II6A) (1629 U), pFY81+22
(I/II6A) (1197 U), pFY81+22(II7C) (747 U), and pFY81+
22 (I/II7C) (664 U) were only 12 to 30% that of the wild-type
pFY81+22 (Table 3). These results together with those of
EMSA assays indicate that (i) a mutation of G to C at position
5 in GTG motif of site II not only eliminates the in vitro binding
activity for Clp (Fig. 5B, probe f and g) but also abolishes the
engA promoter activity, and (ii) a mutation at position 6 or 7 in
site II can greatly reduce the engA expression activation by Clp.
Notably, promoter activity expressed by pFY81+22(I5C)
(1144 U) pFY81+22(I6A) (4844 U), and pFY81+22(I7C)
(3730 U) was 21%, 90%, and 70% that of the wild-type
pFY81+22, respectively (Table 3). These data indicate that
although mutation in site I caused less reduction in Clp bind-
ing in vitro (probes e, h, and k in Table 3 and Fig. 5B), Clp
binding to site I was somehow required for promoter activity
in X. campestris cells. In other words, site I may play an
enhancing role to facilitate binding of Clp to site II in forming
a stable Clp-engA promoter complex in vivo (see below). Other
possibilities include that (i) the binding of Clp on both sites I
and II could result in a stronger stabilization of RNA polymer-
ase in the engA promoter, and (ii) alternatively, a diﬀerent
transcription activator binds to this site in vivo, and this bind-
ing rather than binding of Clp is required for transcription
activation.
3.8. engA promoter resembles class II CRP-dependent promoter
except the presence of tandem Clp sites and a much shorter
spacer than those of tandem CRP sites
The amino acid residues that contact DNA base pairs in
CRP-DNA complex are R180 and E181 in CRP, which are
conserved in Clp, R201 and E202 [26]. The residues (A156,
M157, T158, H159, P160, D161, and G162) in CRP making di-
rect protein–protein interaction with the E. coli RNA polymer-
ase a subunit C-terminal domain (aCTD) in transcription
activation are also highly conserved in Clp (A177, M178,
S179, H180, P181, Q182, and G183) [26,28,29]. The amino
acids similar to the region in E. coli RNA polymerase aCTD
(T285, E286, V287, E288, L289, G315, R317 and L318)
responsible for interaction with CRP are also found in the
X. campestris RNA polymerase aCTD (T284, E285, V286,
E287, L288, G314, K316 and L317) [26,28,29]. With such con-
servations, it is likely that equivalent amino acids of CRP and
Clp make equivalent contacts in the respective protein-
promoter complexes and direct protein–protein interactions
with the RNA polymerase in transcription activation. How-
ever, several observations suggest signiﬁcant diﬀerences be-
tween the situations of regulation by CRP and Clp. First,
Clp and CRP share only a moderate degree of identity (45%)
[26]. Second, no signiﬁcant level of cyclic AMP is detectable
in X. campestris [8] and no gene showing signiﬁcant identity
to cya, encoding adenylate cyclase for the synthesis of cAMP
in E. coli, is found in the fully sequenced genome of Xc17
[http://xcc.life.nthu.edu.tw/] and ATCC33913 [30]. These to-
gether suggest that cAMP is not synthesized by X. campestris.
Third, although a region similar to the cAMP binding site in
CRP (G71, E72, R82, S83, T127 and T128) is present in Clp
Fig. 5. EMSA of Clp binding to wild-type and mutant engA promoter fragments. (A) Location of site-speciﬁc mutations and their corresponding
sequences. Primers used for PCR ampliﬁcation are listed in Table 2. (B) Eﬀects of mutations on the electrophoretic mobility of the X. campestris engA
promoter in the presence of Clp protein. The electrophoretic mobility of probes in the presence (+) or absence () of X. campestris Clp protein
(0.5 lg) is shown.
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the amino acids diﬀerent in charge and size (underlined) might
have caused a loss of the binding aﬃnity to cAMP [26,31,32].
Fourth, Clp can partially complement the deﬁciency in CRP in
cya crp double mutant of E. coli, indicating functioning of Clp
without cAMP [8].
The CRP-dependent E. coli promoters can be grouped into
three classes [29,33,34]. Class I, requiring only CRP for tran-
scription activation, has a single CRP-binding site centered
at 61.5, 71.5, 81.5, or 91.5 relative to TIS. Class II,
requiring only CRP, bears a single CRP-recognition site over-
lapped with the 35 box and centered at 41.5. Class III,
requiring multiple activator molecules for full transcription
activation, i.e. two or more CRP molecules, or one or moreCRP molecules plus one or more regulon-speciﬁc activator
molecules. With the major Clp-binding site centered at 42.5
relative to TIS and overlapped with 35 box, the engA pro-
moter resembles the class II CRP-dependent promoter, except
that a tandem Clp site (centered at 69.5) is present upstream.
The role of upstream tandem bound CRP has been investi-
gated at two sets of semisynthetic promoters [35–40]. The re-
sults showed that tandem binding causes synergistic eﬀects
on transcription activation and the synergy depends on precise
location of the upstream site, with the best eﬀects being re-
sulted from the binding to a site situated 40 or 50 bp upstream
[40]. In both instances, the evidence suggests that both bound
CRP make contact with RNA polymerase and the stimulated
eﬀect of the upstream-bound CRP is due to its direct interac-
Table 3
Promoter activities expressed from diﬀerent transcriptional fusion constructs with mutant engA promoters and Clp-binding activities of the
corresponding mutant probes in EMSA analysis
Fusion construct b-Galactosidasea (Miller unit) Promoter activity (%) Probe Shifted probeb (%)
pFY81+22 5367 100.0 a 100.0
pFY81+22(I5C) 1144 21.3 e 71.7
pFY81+22(II5C) 137 2.6 f 9.3
pFY81+22(I/II5C) 146 2.7 g 8.3
pFY81+22(I6A) 4844 90.3 h 81.2
pFY81+22(II6A) 1629 30.4 i 79.8
pFY81+22(I/II6A) 1197 22.3 j 58.3
pFY81+22(I7C) 3730 69.5 k 79.9
pFY81+22(II7C) 747 13.9 l 46.4
pFY81+22(I/II7C) 664 12.4 m 44.7
aCells of the wild-type Xc17 carrying diﬀerent constructs, after growing for 48 h in the LB medium, were harvested and the cell-free extract prepared
from these cells were subjected to b-galactosidase assays. Enzyme activities were from the average of three independent experiments.
bBinding activity relative to that of the wild-type fragment (probe a).
3532 Y.-M. Hsiao et al. / FEBS Letters 579 (2005) 3525–3533tion with the spare aCTD of RNA polymerase [35]. With a
spacer of only 27 nt, the distance between Clp site I and II
of the engA promoter is much shorter. The diﬀerence in pro-
moter architecture suggests that this spacing may be an opti-
mal distance to accommodate synergistic eﬀects in
transcription activation by Clp, which is able to act without
the formation of a Clp-cAMP complex even though it has
the same DNA binding speciﬁcity as CRP.
3.9. engA appears to be the ﬁrst gene whose promoter is known
to be regulated by a direct binding of Clp in X. campestris
So far, two other X. campestris genes have also shown to be
positively regulated by Clp in our laboratory, the prt1 gene
encoding the major extracellular protease and the groESL op-
eron encoding the heat shock proteins. However, EMSA tests
showed that Clp activates the transcription of these genes with-
out a direct binding to their promoters [15,16,41]. In other
words, the regulation appears to be in a hierarchical manner
involving a direct binding of a secondary regulatory protein(s),
instead of Clp, whose expression depends on Clp. Thus, since
no other reports have been documented, transcription of engA
appears to be the ﬁrst known to be regulated by a direct bind-
ing of Clp in X. campestris.
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